SeizEAR Safety Study
Part of paid clinical trials in New York, New York.
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Study ID
- NCT07088835
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- SeizEAR — DEVICEThe in-ear electrode is a two-electrode device that fits snugly into the ear canal of the user. The device electrodes consist of a Ag/AgCl layer over a substrate. In one iteration, the substrate is a silicone rubber. In another iteration, the substrate is copper. The copper iteration consists of a Ag/AgCl ink that is manually applied to the copper, whereas the other iteration is purchased in a finished state with the Ag/Agel already adhered to the silicone. The electrodes are attached to a foam earpiece during the molding process. The foam earbud is made in-house and can be designed to be more firm or less firm.
Study Details
Determine the safety and feasibility of an in-ear device to measure seizures or suspected seizures compared to the standard scalp-based electroencephalogram (EEG). The study team anticipates enrolling five healthy participants through meeting announcements and a research email list serv in the Neurology Dept. Based on the appropriate positive initial test of healthy individuals, test the in-ear device on 10 participants with seizures or suspected seizures scheduled for a clinical scalp EEG test.
Key Dates
- Start date
- May 8, 2025
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Healthy ParticipantsParticipants with no seizures or suspected temporal lobe seizures.
- Experimental: Participants with seizures or suspected temporal lobe seizuresParticipants with seizures or suspected temporal lobe seizures scheduled for a clinical EEG.
Primary Outcome Measure
Sensitivity [ Time Frame: at week 16 ]
Central Contacts
- Mary Catherine George, PhD212-241-0784
- Toni Kavanagh, NP212-241-2401
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | - |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- An Examination of Cognitive and Sensorimotor Processes in Patients With EpilepsyEnrolling By Invitation · Northwell Health · Great Neck, New York
- Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental DisordersRecruiting · Southwest Autism Research & Resource Center · Phoenix, Arizona
- Methylphenidate for the Treatment of Epilepsy-related Cognitive DeficitsPHASE4 · Recruiting · VA Office of Research and Development · Miami, Florida
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresPHASE3 · Recruiting · UCB Biopharma SRL · Hawthorne, New York